Abstract
Protein mobility, chromatin movement and the formation of molecular assemblies in the cell nucleus have, until fairly recently, been viewed in a pseudo-static light, even though the dynamics of other cellular regions have been partly, or wholly understood for a number of years. The new science that has recently emerged on nuclear kinetics reveals a nucleus that has mobile proteins, dynamic intra-nuclear compartments and chromatin that is far from being static. This new knowledge has given scientists a deeper understanding of transcription, translation and the cell cycle. With these fundamentals of nuclear operation, has come a greater understanding of genetics and genetic diseases – so much so that, by way of example, diseases of chromatin have as a category, made significant advances. Whilst certain questions relating to protein mobility, chromatin movement and the formation of molecular assemblies have been answered, many key questions still remain. Those remaining questions have now started to be answered by technological developments. This review marshals the latest scientific evidence on the molecular kinetics of the nucleus that has arisen from a number of recent, elegant experiments.
Keywords: Dynamics, protein dynamics, chromatin dynamics, residence time, surface profile
Current Chemical Biology
Title: Molecular Kinetics and Targeting Within the Nucleus
Volume: 2 Issue: 3
Author(s): Christopher M. Wood
Affiliation:
Keywords: Dynamics, protein dynamics, chromatin dynamics, residence time, surface profile
Abstract: Protein mobility, chromatin movement and the formation of molecular assemblies in the cell nucleus have, until fairly recently, been viewed in a pseudo-static light, even though the dynamics of other cellular regions have been partly, or wholly understood for a number of years. The new science that has recently emerged on nuclear kinetics reveals a nucleus that has mobile proteins, dynamic intra-nuclear compartments and chromatin that is far from being static. This new knowledge has given scientists a deeper understanding of transcription, translation and the cell cycle. With these fundamentals of nuclear operation, has come a greater understanding of genetics and genetic diseases – so much so that, by way of example, diseases of chromatin have as a category, made significant advances. Whilst certain questions relating to protein mobility, chromatin movement and the formation of molecular assemblies have been answered, many key questions still remain. Those remaining questions have now started to be answered by technological developments. This review marshals the latest scientific evidence on the molecular kinetics of the nucleus that has arisen from a number of recent, elegant experiments.
Export Options
About this article
Cite this article as:
Wood M. Christopher, Molecular Kinetics and Targeting Within the Nucleus, Current Chemical Biology 2008; 2 (3) . https://dx.doi.org/10.2174/2212796810802030229
DOI https://dx.doi.org/10.2174/2212796810802030229 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nucleoside Transport as a Potential Target for Chemotherapy in Malaria
Current Pharmaceutical Design Survey of Recent Literature Related to the Biologically Active 4(3H)-Quinazolinones Containing Fused Heterocycles
Current Medicinal Chemistry Dynamics of CD86 Expression on Allergic Inflammation - New Insights
Recent Patents on Inflammation & Allergy Drug Discovery Advancement and Strategies for the Development of Peptide-drug Conjugates: Pharmacokinetic Modulation, Role and Clinical Evidence against Cancer Management
Current Cancer Drug Targets Signal Transduction Pathways and Transcription Factors as Therapeutic Targets in Inflammatory Disease: Towards Innovative Antirheumatic Therapy
Current Pharmaceutical Design On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
Current Drug Metabolism Receptor Tyrosine Kinases Take a Direct Route to Mitochondria: An Overview
Current Protein & Peptide Science Never Sleep with Baby? Or Keep Me Close But Keep Me Safe: Eliminating Inappropriate “Safe Infant Sleep” Rhetoric in the United States
Current Pediatric Reviews The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development
Current Cancer Drug Targets Topical Melatonin Niosome Gel for the Treatment of 5-FU-Induced Oral Mucositis in Mice
Current Drug Delivery Small Molecule Toxins Targeting Tumor Receptors
Current Pharmaceutical Design <i>In Silico</i> Study of Potential Cross-Kingdom Plant MicroRNA Based Regulation in Chronic Myeloid Leukemia
Current Pharmacogenomics and Personalized Medicine Lamellarins, from A to Z: A Family of Anticancer Marine Pyrrole Alkaloids
Current Medicinal Chemistry - Anti-Cancer Agents Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?
Anti-Cancer Agents in Medicinal Chemistry Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches
CNS & Neurological Disorders - Drug Targets Signal Transduction and Photodynamic Therapy
Current Signal Transduction Therapy Preliminary Studies on the Activity of Mixed Polyphenol-Heterocyclic Systems Against B16-F10 Melanoma Cancer Cells
Medicinal Chemistry Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets